CONSENT, AMENDMENT AND WAIVERConsent, Amendment and Waiver • March 24th, 2022 • NANOMIX Corp • Pharmaceutical preparations
This CONSENT, AMENDMENT AND WAIVER (this “Consent”) is made and entered into as of March 22, 2022 by and among Nanomix Corporation, a Delaware corporation (which was formerly known as Boston Therapeutics, Inc.) (the “Company”) and HT Investments MA LLC (the “Investor”).
CONSENT, AMENDMENT AND WAIVERConsent, Amendment and Waiver • March 1st, 2022 • NANOMIX Corp • Pharmaceutical preparations
This CONSENT, AMENDMENT AND WAIVER (this “Consent”) is made and entered into as of February 24, 2022 by and among Nanomix Corporation, a Delaware corporation (which was formerly known as Boston Therapeutics, Inc.) (the “Company”) and HT Investments MA LLC (the “Investor”).
